| Infectious Diseases and Tuberculosis | Lifetime | 59 | IN 5 | 99.28 |
| Parasitic infections in humans and animals | Lifetime | 38 | IN 2 | 99.11 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 42 | IN 3 | 98.02 |
| Long-Term Effects of COVID-19 | Lifetime | 385 | IN 4 | 96.96 |
| Bacterial Infections and Vaccines | Lifetime | 275 | IN 4 | 97.71 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 357 | IN 7 | 97.17 |
| Orthopedic Infections and Treatments | Lifetime | 532 | IN 5 | 97.48 |
| Peripheral Neuropathies and Disorders | Lifetime | 377 | IN 3 | 97.10 |
| Amoebic Infections and Treatments | Lifetime | 215 | IN 8 | 95.65 |
| Hematological disorders and diagnostics | Lifetime | 339 | IN 8 | 95.37 |
| Virology and Viral Diseases | Lifetime | 522 | IN 6 | 96.20 |
| Congenital Anomalies and Fetal Surgery | Lifetime | 610 | IN 8 | 95.90 |
| Diagnosis and treatment of tuberculosis | Lifetime | 498 | IN 39 | 94.29 |
| Parasite Biology and Host Interactions | Lifetime | 871 | IN 5 | 95.72 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 608 | IN 12 | 92.87 |
| Leprosy Research and Treatment | Lifetime | 301 | IN 38 | 92.60 |
| Neurological Complications and Syndromes | Lifetime | 567 | IN 4 | 91.96 |
| Neurological and metabolic disorders | Lifetime | 718 | IN 14 | 89.42 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 890 | IN 12 | 71.18 |
| Drug-Induced Ocular Toxicity | Lifetime | 717 | IN 11 | 70.10 |
| Intramuscular injections and effects | Lifetime | 838 | IN 15 | 63.93 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 35 | IN 4 | 95.52 |
| Virology and Viral Diseases | 2021-2025 | 96 | IN 6 | 91.27 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 320 | IN 2 | 91.68 |
| Parasitic infections in humans and animals | 2021-2025 | 102 | IN 1 | 89.18 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 456 | IN 7 | 86.49 |
| Bacterial Infections and Vaccines | 2021-2025 | 329 | IN 4 | 85.07 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 232 | IN 4 | 80.31 |
| Intramuscular injections and effects | 2021-2025 | 91 | IN 4 | 72.79 |
| Congenital Anomalies and Fetal Surgery | 2021-2025 | 788 | IN 6 | 69.74 |
| Syphilis Diagnosis and Treatment | 2021-2025 | 540 | IN 4 | 70.51 |
| Leprosy Research and Treatment | 2021-2025 | 278 | IN 31 | 67.88 |
| Parvovirus B19 Infection Studies | 2021-2025 | 818 | IN 12 | 56.68 |
| Amoebic Infections and Treatments | 2021-2025 | 688 | IN 46 | 50.45 |
| Neurological and metabolic disorders | 2021-2025 | 574 | IN 51 | 48.30 |
